These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17906617)

  • 1. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma.
    Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G
    Mod Pathol; 2008 Jan; 21(1):1-6. PubMed ID: 17906617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
    El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
    Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.
    de Oliveira D; Dall'Oglio MF; Reis ST; Zerati M; Souza IC; Leite KR; Srougi M
    Urol Oncol; 2014 Jul; 32(5):601-6. PubMed ID: 24629495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
    El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
    Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
    La Rochelle J; Klatte T; Dastane A; Rao N; Seligson D; Said J; Shuch B; Zomorodian N; Kabbinavar F; Belldegrun A; Pantuck AJ
    Cancer; 2010 Oct; 116(20):4696-702. PubMed ID: 20629029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma.
    Massari F; Ciccarese C; Bria E; Porta C; La Russa F; Knuutila S; Artibani W; Porcaro AB; Bimbatti D; Modena A; Sava T; Tortora G; Cheng L; Eccher A; Cima L; Pedron S; Ghimenton C; Martignoni G; Brunelli M
    Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):39-43. PubMed ID: 26509904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma.
    Narimatsu T; Matsuura K; Nakada C; Tsukamoto Y; Hijiya N; Kai T; Inoue T; Uchida T; Nomura T; Sato F; Seto M; Takeuchi I; Mimata H; Moriyama M
    Cancer Med; 2015 Jan; 4(1):112-24. PubMed ID: 25315157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer.
    Eichenauer T; Simmendinger L; Kluth M; Chirico V; Luebke AM; Höflmayer D; Hinsch A; Jacobsen F; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Tsourlakis MC; Büscheck F; Bernreuther C; Clauditz T; Lebok P; Simon R; Sauter G; Wilczak W; Fraune C
    Urol Oncol; 2020 Jun; 38(6):605.e1-605.e8. PubMed ID: 32241691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression in clear cell renal cell carcinoma identified by gene expression profiling.
    Lane BR; Li J; Zhou M; Babineau D; Faber P; Novick AC; Williams BR
    J Urol; 2009 Feb; 181(2):849-60. PubMed ID: 19095258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.
    Di Nunno V; Mollica V; Brunelli M; Gatto L; Schiavina R; Fiorentino M; Santoni M; Montironi R; Caliò A; Eccher A; Milella M; Martignoni G; Brunocilla E; Massari F
    Mol Diagn Ther; 2019 Oct; 23(5):569-577. PubMed ID: 31332726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
    Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
    J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis.
    Monzon FA; Alvarez K; Peterson L; Truong L; Amato RJ; Hernandez-McClain J; Tannir N; Parwani AV; Jonasch E
    Mod Pathol; 2011 Nov; 24(11):1470-9. PubMed ID: 21725288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
    J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.
    Presti JC; Wilhelm M; Reuter V; Russo P; Motzer R; Waldman F
    J Urol; 2002 Mar; 167(3):1464-8. PubMed ID: 11832771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinoma.
    Köhn L; Svenson U; Ljungberg B; Roos G
    Appl Immunohistochem Mol Morphol; 2015; 23(5):334-42. PubMed ID: 24992170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.
    Nejati R; Wei S; Uzzo RG; Poureghbali S; Pei J; Talarchek JN; Ruth K; Dulaimi E; Kutikov A; Testa JR; Al-Saleem T
    Clin Genitourin Cancer; 2020 Feb; 18(1):56-61. PubMed ID: 31648964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.